Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORL-1B in Biotinidase Deficiency
NCT03269045Phase 2Completed
- Sponsor
- Orpha Labs
- Start
- Aug 2013
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ORL-1B in biotinidase deficiency (BTD), sponsored by Orpha Labs. Started Aug 2013; status: completed.
02
Drugs
ORL-1B
03
Conditions
biotinidase deficiency (BTD)
Beyond the preview
Go deeper on NCT03269045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269045.